A recent FiercePharma article discussed the recall of Pfizer’s menopause drug, Duavee. The company voluntarily recalled two batches of the drug, which is marketed as Duavive abroad, over concerns of faulty packaging that might have reduced efficacy. A flaw in the drug’s foil laminate pouch allows oxygen to pass through, lowering the dissolution rate of the active pharmaceutical ingredient, bazedoxifene acetate.
Quick Hits: Faulty Packaging Prompts Pfizer Recalls in UK
The drug’s packaging featured a flaw that lowered the dissolution rate of the API.
Jun 26, 2020
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
